Featured Research

from universities, journals, and other organizations

Researchers discover new genetic errors that could cause deadly leukemia

Date:
October 23, 2013
Source:
Centro Nacional de Investigaciones Oncologicas (CNIO)
Summary:
Acute dendritic leukemia is a rare type of leukemia, but one with the worst prognosis -- the average patient survival rate is just 12-14 months, and it is difficult to treat. Now researchers have, for the first time, sequenced the exome of dendritic cell leukemia. The analyses uncover new genetic pathways that could revolutionize treatment guidelines for these patients.

Acute dendritic leukemia is a rare type of leukemia, but one with the worst prognosis -- the average patient survival rate is just 12-14 months -- that is difficult to treat. Juan Cruz Cigudosa's team, from the Spanish National Cancer Research Centre's (CNIO) Molecular Cytogenetics Group, has for the first time sequenced the exome -the coding, or protein-generating, regions of the genome -- of dendritic cell leukemia.

The analyses, published in Leukemia, the world's leading journal in onco- haematology, uncover new genetic pathways that could revolutionise treatment guidelines for these patients.

"Epigenetic" genes are altered in most cases

For the first time in human leukemias, scientists have described mutations in four genes (IKZF3, HOXB9, UBE2G2 and ZEB2) that have important cellular functions, such as gene regulation and cellular differentiation.

"In addition to these genes, we have found that more than half of the cases harbour mutations in epigenetic genes at diagnosis -- those genes that introduce chemical modifications in the DNA -- something that had never been observed in this type of leukemia," says Cigudosa. "Therapies directed against these epigenetic genes already exist, so these patients could also benefit from them."

In summary, the genetic profile of acute dendritic cell leukemia, currently treated as a lymphoid leukemia, is similar to that of myeloid leukemia. "These results suggests a change in the treatment guidelines for these patients, who were completely misplaced," says Juliane Menezes, the first author of the study.

According to Cigudosa, "this study is a clear example of the role of genomics in translational research being carried out by Spanish scientists, in general, and more specifically at CNIO."

To carry out this work, the authors analysed the exome of three patients diagnosed with dendritic cell leukemia and validated the results using a panel of 38 genes and 25 additional patients (known as a targeted resequencing strategy), coming from 9 Spanish hospitals.


Story Source:

The above story is based on materials provided by Centro Nacional de Investigaciones Oncologicas (CNIO). Note: Materials may be edited for content and length.


Journal Reference:

  1. J Menezes, F Acquadro, M Wiseman, G Gómez-López, R N Salgado, J G Talavera-Casañas, I Buño, J V Cervera, S Montes-Moreno, J M Hernández-Rivas, R Ayala, M J Calasanz, M J Larrayoz, L F Brichs, M Gonzalez-Vicent, D G Pisano, M A Piris, S Álvarez, J C Cigudosa. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm. Leukemia, 2013; DOI: 10.1038/leu.2013.283

Cite This Page:

Centro Nacional de Investigaciones Oncologicas (CNIO). "Researchers discover new genetic errors that could cause deadly leukemia." ScienceDaily. ScienceDaily, 23 October 2013. <www.sciencedaily.com/releases/2013/10/131023125707.htm>.
Centro Nacional de Investigaciones Oncologicas (CNIO). (2013, October 23). Researchers discover new genetic errors that could cause deadly leukemia. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/10/131023125707.htm
Centro Nacional de Investigaciones Oncologicas (CNIO). "Researchers discover new genetic errors that could cause deadly leukemia." ScienceDaily. www.sciencedaily.com/releases/2013/10/131023125707.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins